8305 NW 27th Street
About TissueTechTissueTech, Inc. is pioneering the field of regenerative medicine through our superior platform technology, cutting edge scientific innovation, and commitment to commercial excellence. The Company markets innovative amniotic and umbilical cord-based products used by physicians around the world in eye care, wound care, and orthopedics. TissueTech’s proprietary technology is clinically proven to promote regenerative healing.
CEO: Amy Tseng
Chief Scientific Officer: Scheffer C.G. Tseng, MD, PhD
CFO: Michael Cornelius
Chief Commercial Officer: Tom Daniells
8 articles with TissueTech
Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation
TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office.
TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs.
New Chief Commercial Officer brings broad experience in regenerative medicine
Dec. 11, 2017 15:19 UTC AMNIOX Medical Awarded Premier Agreement for Regenerative Medicine Products Offers Access to Amniotic Membrane Products to Premier Members ATLANTA--( BUSINESS WIRE )-- AMNIOX Medical, Inc., a TissueTech, Inc. company, has been awarded a group purchasing agreement for Regenerative Skin Grafting Products with Premier. Effective January 1, 2018, the new agreement allows Premier members, at the
Bio-Tissue Announces Study that Demonstrates Cryopreserved Amniotic Membrane Graft Reduces Recurrence After Pterygium Surgery
In this retrospective review, 556 eyes representing 535 patients, who had pterygium excision (527 primary, 29 recurrent) were treated with adjunctive cryopreserved amniotic membrane.
TissueTech Awarded Four Patents For Proprietary Technology To Use Placental Tissue For Regenerative Medicine
TissueTech Highlights Clinical Experience Showing In-Utero Spina Bifida Repair with NEOX Wound Allograft